SEC Tracker
Get the app

DataMeds AI MEDS

DataMeds AI (MEDS) announces new deal terms.

Item 1.01 Enters material agreement, Item 7.01 Investor disclosure

Form
8-K
Filed
Importance
Major
  1. Company entered into a non-binding Second A&R LOI with multiple parties.
  2. Acquisition would involve issuing shares to EOS, Scilex, Datavault, HBA, THI, and REBOOT.
  3. Post-closing ownership would be 89.5% for these parties, with 10.5% for existing shareholders.
  4. Royalties would be 6% for REBOOT and 5% for EOS and Scilex.

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when DataMeds AI files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 5122 and related industry codes: the same peer list as the financial tables.

  1. Sharing Services Global SHRG
  2. Cosmos Health COSM public float $10M, Jun 30, 2025
  3. Stemtech STEK public float $6M, Jun 30, 2025